NCPA on Biden drug pricing plan: Include PBMs/insurers to truly lower costs
ALEXANDRIA, Va. — National Community Pharmacists Association CEO B. Douglas Hoey, pharmacist, MBA issued the following statement today in response to President Biden’s drug pricing remarks: “The president’s plan takes a swing at lowering drug prices and whiffs by ignoring the most glaring cause of high drug costs. Pharmacy benefit managers and their insurer-partner/owners continue to
